https://www.selleckchem.com/products/ldc7559.html
FC levels normalised in 66 (84.6%) patients, including 60 and 6 patients treated for 2 and 4weeks, respectively. The remaining 12 (15.4%) patients with persistently elevated FC levels despite 4weeks of treatment also showed a significant decline in their final FC levels compared with the baseline, accompanied with a significant improvement in abdominal symptoms (p=0.001). A cutoff baseline FC value of 148.5μg/g could predict non-responders with 100% sensitivity and 50% specificity. Short-course oral rifaximin treatment results in FC nor